Renal effects of nifedipine and captopril in patients with essential hypertension and reduced renal reserve. 1994

C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
Institute of Clinical Medicine and Nephrology, University of Parma, Italy.

In this study we investigated the short-term effects of calcium channel blockers and angiotensin-converting enzyme inhibitors on renal hemodynamics and the urinary excretion of proteins with different relative mass in subjects with mild to moderate essential hypertension and apparently normal glomerular filtration rate but reduced renal functional reserve. Sixteen subjects underwent the following four treatments: (1) low-protein meal (0.2 g protein/kg body wt), (2) high-protein meal (1.3 g protein/kg body wt), (3) high-protein meal plus oral nifedipine (20 mg), and (4) high-protein meal plus oral captopril (50 mg). Two urine samples were obtained after meals. Blood samples were drawn at the midpoint of each 120-minute urine collection period. Urine and serum were tested for total protein, immunoglobulin G, albumin, alpha 1-microglobulin, retinol binding protein, and beta 2-microglobulin. Glomerular filtration rate and renal plasma flow were assessed by iothalamate and p-aminohippuric clearance, respectively. Compared with the high-protein meal alone, nifedipine elicited a clear-cut increase in the urinary excretion of total protein (+60%, P < .01), immunoglobulin G (+58%, P < .01), albumin (+25%, P < .05), retinol binding protein (+47%, P < .05), and beta 2-microglobulin (+52%, P < .05); captopril decreased the urinary excretion rate of immunoglobulin G (-26%, P < .05), albumin (-22%, P < .05), and beta 2-microglobulin (-34%, P < .05). The ratio between the clearances of immunoglobulin G and albumin was higher after nifedipine (+21%, P < .01) and unchanged after captopril (-9%, P = NS) compared with the high-protein meal alone.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses

Related Publications

C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
January 1987, Journal of cardiovascular pharmacology,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
December 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
January 1994, Journal of Tongji Medical University = Tong ji yi ke da xue xue bao,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
October 1988, American journal of hypertension,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
July 1988, American journal of hypertension,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
April 1982, The American journal of cardiology,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
April 1982, The American journal of cardiology,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
January 1981, European journal of clinical pharmacology,
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
May 1988, Hypertension (Dallas, Tex. : 1979),
C Buzio, and G Regolisti, and F Perazzoli, and A Mutti, and E Bergamaschi, and A Borghetti
June 1987, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!